These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4296229)

  • 1. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report.
    Tate CF; Viamonte M; Agnew JR
    Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229
    [No Abstract]   [Full Text] [Related]  

  • 2. Bronchial artery perfusion for treatment of advanced lung cancer.
    Cliffton EE
    Cancer; 1969 May; 23(5):1151-7. PubMed ID: 4180692
    [No Abstract]   [Full Text] [Related]  

  • 3. Bronchogenic carcinoma: nitrogen mustard as a surgical adjuvant and factors influencing survival. University surgical adjuvant lung project.
    Slack NH
    Cancer; 1970 May; 25(5):987-1002. PubMed ID: 4315360
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytostatic infusion into bronchial arteries in bronchogenic carcinoma.
    Ekholm S; Albrechtsson U; Hellekant C; Jonsson K; Nyman U; Tylén U
    Ann Radiol (Paris); 1980; 23(4):346-8. PubMed ID: 7387096
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective bronchial artery perfusion with cisplatin in the treatment of inoperable bronchogenic carcinoma].
    Liu ZJ
    Zhonghua Fang She Xue Za Zhi; 1987 Feb; 21(1):4-7. PubMed ID: 2954790
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of chemotherapy in the treatment of primary bronchial cancers].
    Clément F
    Bronches; 1972; 22(3):176-89. PubMed ID: 4349927
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
    Takita H; Brugarolas A
    J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bronchial arteriography and intraarterial chemotherapy in bronchogenic carcinoma (author's transl)].
    Hellekant C
    Radiologe; 1979 Dec; 19(12):521-7. PubMed ID: 229511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced lung cancer treated with cyclophosphamide.
    Davis HL; Ramirez G; Korbitz BC; Ansfield FJ
    Dis Chest; 1969 Dec; 56(6):494-500. PubMed ID: 4187520
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of chemotherapy in lung cancer (controlled trials).
    Shnider BI
    Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of lung cancer with cyclophosphamide from the cytological point of view].
    Simecek C
    Bronches; 1971; 21(2):181-5. PubMed ID: 4331189
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intra-arterial drug infusion via the bronchial artery in the treatment of bronchogenic carcinoma].
    Wang ZT
    Zhonghua Fang She Xue Za Zhi; 1988 Aug; 22(4):216-9. PubMed ID: 3145173
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
    Brunner KW; Marthaler T; Müller W
    Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Three years of experience in the polychemotherapy of inoperable bronchial carcinoma].
    Wrbka E
    Wien Med Wochenschr; 1974 Jul; 124(30):467-73. PubMed ID: 4139820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.